miR-23a mediates resistance to hypomethylating agents in myeloid neoplasms.
Mayer MC, Berg JL, Perfler B, Hatzl S, Herzog SA, Bachmaier G, Berghold A, Reinisch A, Wölfler A, Sill H, Zebisch A.
Mayer MC, et al. Among authors: berghold a.
Ann Hematol. 2021 Nov;100(11):2845-2847. doi: 10.1007/s00277-021-04598-6. Epub 2021 Jul 22.
Ann Hematol. 2021.
PMID: 34291333
No abstract available.